1,056 results match your criteria: "Inner Ear Autoimmune Disease"

Use of biologics for treatment of autoimmune inner ear disease.

Am J Otolaryngol

September 2022

Department of Otolaryngology-Head and Neck Surgery Texas Medical Branch, Galveston, TX, United States of America.

Article Synopsis
  • The study investigates the effectiveness of biologic medications for treating Autoimmune Inner Ear Disease (AIED), which can lead to hearing loss, by reviewing existing literature on their impact on hearing outcomes.
  • After screening 174 abstracts, the review included 12 studies, featuring a mix of randomized control trials and cohort studies, and identified seven different biologic drugs targeting specific cellular pathways.
  • The findings showed variable effects of these medications on hearing loss, with some improving related symptoms like vertigo and tinnitus, but the overall evidence is inconclusive, highlighting the need for more comprehensive research.
View Article and Find Full Text PDF

Autoimmune Hearing Loss: A Diagnostic Challenge.

J Clin Med

August 2022

1st Otolaryngology Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA Hospital, 54636 Thessaloniki, Greece.

Autoimmune hearing loss (AIHL) is a clinical disease and may involve the deposition of immune complexes in the labyrinth vessels, the activation of the complement system, the functional alteration in T-cell subpopulations, or an inflammation process in the inner ear [...

View Article and Find Full Text PDF

Objective: IgG4-related disease (IgG4-RD) involving the temporal bone is an uncommon and underrecognized pathology often mistaken for malignancy. This systematic review is the first that aims to thoroughly analyze IgG4-RD of the temporal bone.

Databases Reviewed: Ovid MEDLINE, EMBASE, Cochrane Library, and Google Scholar.

View Article and Find Full Text PDF

We report the case of a woman in her 30s who was referred to the ear, nose and throat department with sudden onset left-sided sensorineural hearing loss (SNHL), left anterior uveitis and erythematous lower limb lesions with bilateral pitting oedema. Based on her symptoms, an underlying inflammatory systemic disease was suspected. Autoantibodies were negative but an X-ray and high-resolution CT scan of the chest were suggestive of sarcoidosis, which was confirmed on endoscopic bronchial biopsy.

View Article and Find Full Text PDF

Objective: To explore the clinical characteristics of patients with dizziness/vertigo who showed a dissociation between the results of the caloric test and video head impulse test (vHIT).

Methods: A total of 327 patients who complained of dizziness/vertigo were continuously included. All patients underwent both the horizontal vHIT (h-vHIT) and caloric tests.

View Article and Find Full Text PDF

Assessment of Metabolic Markers and Osteoporosis in 250 Patients with Superior Semicircular Canal Dehiscence Treated With Middle Fossa Craniotomy.

World Neurosurg

October 2022

Department of Neurosurgery, University of California-Los Angeles, Los Angeles, California, USA; Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, California, USA; Department of Head and Neck Surgery, University of California-Los Angeles, Los Angeles, California, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, California, USA; Los Angeles Biomedical Research Institute, University of California-Los Angeles, Los Angeles, California, USA; Harbor-UCLA Medical Center, University of California-Los Angeles, Los Angeles, California, USA; David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA. Electronic address:

Background: Superior semicircular canal dehiscence (SSCD) is caused by bony defects in the osseous shell of the arcuate eminence separating the labyrinth and the intracranial space. This pathologic third window causes hydroacoustic transmission resulting in debilitating symptoms. We examine the pathophysiologic association between metabolic markers, previous medical history, and SSCD symptoms before and after middle fossa craniotomy (MFC) treatment.

View Article and Find Full Text PDF

Acupuncture in the treatment of Dry Eye Syndrome with anxiety symptoms. A case report.

Eur J Transl Myol

June 2022

Italian Association for Scientific Research and Updating (AIRAS) Padua.

Dry Eye Syndrome (DES) is an eye disorder caused by alteration of production or composition of tear film. Symptoms include dry eye dryness, burning, itching and pain, and often is associated with emotional stress, anxiety and depression. Evidence of the effectiveness of acupuncture to treat DES has recently appeared in literature but not on acupuncture treatment of DES related anxiety or depression symptoms.

View Article and Find Full Text PDF

Role of Inner Ear Macrophages and Autoimmune/Autoinflammatory Mechanisms in the Pathophysiology of Inner Ear Disease.

Front Neurol

April 2022

Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Macrophages play important roles in tissue homeostasis and inflammation. Recent studies have revealed that macrophages are dispersed in the inner ear and may play essential roles in eliciting an immune response. Autoinflammatory diseases comprise a family of immune-mediated diseases, some of which involve sensorineural hearing loss, indicating that similar mechanisms may underlie the pathogenesis of immune-mediated hearing loss.

View Article and Find Full Text PDF

Objective: Autoimmune inner ear disease (AIED) is a rare disorder characterized by rapidly progressive, sensorineural hearing loss that demonstrates good responsiveness to corticosteroid and immunosuppressive therapy. The pathophysiology is likely driven by chronic trafficking of immune cells into the inner ear, targeting inner ear proteins to coordinate inflammation. Suppression or modulation of the immune response can minimize cochleitis allowing for potential recovery of hearing.

View Article and Find Full Text PDF

Autoimmune inner ear disease (AIED) is a rare clinical entity. Its pathogenicity, heterogenous clinical presentation in the context of secondary systemic autoimmune disease and optimal treatment avenues remain poorly understood. Vestibular impairment occurring in the context of AIED is rarely subject to detailed investigation given that the auditory symptoms and their responsiveness to immunosuppression are the focus of the few proposed diagnostic criteria for AIED.

View Article and Find Full Text PDF

Meniere's disease (MD) is a chronic disease that causes episodic vertigo, fluctuating hearing loss, and aural fullness, initially managed by dietary salt reduction, and use of diuretics. Our prior research in autoimmune inner ear disease (AIED) demonstrated that in peripheral blood mononuclear cell (PBMC) from corticosteroid-resistant AIED patients, increased production, processing and release of interleukin-1β (IL-1β) is observed and hearing could be improved with use of anakinra, an interleukin-1 receptor antagonist. We have further identified that in these AIED patients, IL-1β is uniquely processed to a 28 kDa pro-inflammatory product by caspase-7.

View Article and Find Full Text PDF
Article Synopsis
  • Brainstem involvement in Multiple Sclerosis (MS) is a key factor linked to future disability, prompting further research into diagnosis methods.
  • Researchers evaluated 53 MS patients and 40 controls using the Dizziness Handicap Inventory (DHI), Video Head Impulse Test (vHIT), and Cervical Vestibular Evoked Myogenic Potentials (cVEMP) to identify vestibular pathway lesions.
  • Results showed significant differences in vestibular function and response times between MS patients with brainstem involvement and controls, indicating that vHIT and cVEMP could be effective diagnostic tools for MS patients without visible brainstem lesions on MRI.
View Article and Find Full Text PDF

Background: Treatment of many types of hearing instability in humans, including sudden sensorineural hearing loss, Meniere's disease, and autoimmune inner ear disease, rely heavily on the utilization of corticosteroids delivered both by oral and transtympanic routes. Despite this use, there is heterogeneity in the response to treatment with corticosteroids in humans with these diseases. The mechanisms by which corticosteroids exert their effect and the cell types in which they exert their effects in the inner ear remain poorly characterized.

View Article and Find Full Text PDF

Importance: Ménière disease is a rare chronic benign disorder of the inner ear with a natural history of multiple clinical phenotypes of variable severity and a tendency to burnout with time. Although multiple treatment modalities have been shown to improve the disease process-some adversely affecting cochleovestibular function-it remains uncertain whether one, several separate, or a combination of pathophysiologic mechanisms affect the disease process. A scoping review of the evidence underlying proposed pathophysiologic mechanisms of Ménière disease is needed to determine which processes are most likely to be etiopathogenic factors.

View Article and Find Full Text PDF

Cytokines and Inflammation in Meniere Disease.

Clin Exp Otorhinolaryngol

February 2022

Otology and Neurotology Group CTS495, Department of Genomic Medicine, Centre for Genomics and Oncological Research (GENYO), Pfizer-University of Granada-Junta de Andalucía, PTS, Granada, Spain.

Meniere disease (MD) is a rare set of conditions associated with the accumulation of endolymph in the cochlear duct and the vestibular labyrinth with a decrease of endocochlear potential. It is considered a chronic inflammatory disorder of the inner ear with a multifactorial origin. The clinical syndrome includes several groups of patients with a core phenotype: sensorineural hearing loss, episodes of vertigo, and tinnitus with a non-predictable course.

View Article and Find Full Text PDF

Effects of primary Sjögren's syndrome on hearing and vestibular systems.

J Laryngol Otol

December 2022

Department of Otorhinolaryngology - Head and Neck Surgery, Faculty of Medicine, Selçuk University, Konya, Turkey.

Objective: This study aimed to evaluate primary Sjögren's syndrome patients in terms of hearing and vestibular functions.

Methods: The patient group consisted of 35 individuals diagnosed with primary Sjögren's syndrome and a control group of 35 healthy individuals similar in terms of age and gender.

Results: The rate of hearing loss in the patient group was significantly higher than in the control group ( = 0.

View Article and Find Full Text PDF

Otitis media with antineutrophil cytoplasmic antibody-associated vasculitis (OMAAV) has been proposed as a new type of otitis media. The hearing loss caused by OMAAV can be expected to improve with early detection and intervention, but if it continues to worsen and leads to deafness, it is challenging to recover the patient's hearing. When bilateral deafness occurs, cochlear implant (CI) surgery is the only way to improve hearing.

View Article and Find Full Text PDF

(1) Background: A retrospective clinical study was conducted to compare the effectiveness of different pharmacological and non-pharmacological regimens for treating sudden sensorineural hearing loss (SSNHL). (2) Methods: Adult patients ( = 130) diagnosed with sudden sensorineural hearing loss (SSNHL) and hospitalized between 2015 and 2020 were enrolled in this study. Depending on the treatment regimen applied, patients were divided into five groups.

View Article and Find Full Text PDF

Susac's syndrome is a rare microangiopathy affecting small vessels of the retina, inner ear and brain. It is characterised by a triad of symptoms: encephalopathy, visual defects, and sensorineural hearing loss. The disease is probably caused by an autoimmune process.

View Article and Find Full Text PDF

Objective: To assess outcomes in autoimmune inner ear disease (AIED) after cochlear implantation (CI) through systematic review and meta-analysis.

Databases Reviewed: PubMed, MedLine, Embase, and CINAHL.

Methods: Databases were queried for inclusion of AIED patients who underwent CI with outcomes recorded ≥3 months postoperatively.

View Article and Find Full Text PDF

Objective: Immune-mediated inner ear disease (IMIED) might cause severe/profound hearing loss and these patients are considered ideal candidates to cochlear implant (CI) surgery. The aim of the study was to evaluate impedance changes over time.

Method: The Study Group (SG) was composed of CI IMIED patients (31 ears) and a Control Group (CG) of CI patients with hearing loss not related to their immune system (31 ears).

View Article and Find Full Text PDF

Purpose: Fabry disease (FD) is a lysosomal storage disease responsible for cochleovestibular involvement. Exact prevalence and pathophysiological mechanisms behind ENT affections are still poorly known. Treating FD with enzyme replacement therapy (ERT) does not seem to significantly improve the ENT symptoms, while the impact of migalastat has yet to be determined.

View Article and Find Full Text PDF

The occurrence of unilateral sensorineural hearing loss (SNHL) during school age is relatively rare and accounts for approximately 6% of all deafness in childhood. We present two cases involving children who were diagnosed with SNHL associated with Sjögren's syndrome (SS). Case 1: An eight-year-old girl with an approximately two-year clinical history of gradual hearing loss was diagnosed with SNHL associated with SS based on histological findings of inflammation in the salivary glands and the presence of serum anti-Sjögren's syndrome-A antibody.

View Article and Find Full Text PDF